Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank33
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P33
Within normal range
vs 2Y Ago
-10.3x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$-123.34M+26.4%
2024$-167.65M-1506.6%
2023$11.92M+106.6%
2022$-179.87M-140.5%
2021$-74.80M-103.8%
2020$-36.70M-243.4%
2019$-10.69M-